Physician profile
Eric J Root
NPI 1528445202
$909.28
in general payments reported to CMS, 2019-2025
14 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.14 · 2020: $185 · 2021: $249 · 2022: $99.21 · 2023: $115 · 2024: $78.07 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $366.69 | 2021-2025 | Vraylar |
| Lilly USA, LLC | $114.22 | 2020-2024 | Mounjaro |
| Merck Sharp & Dohme LLC | $72.16 | 2020-2021 | |
| Allergan, INC. | $63.39 | 2020 | |
| Novo Nordisk INC | $53.51 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.06 | 2020-2023 | Jardiance, Tradjenta |
| Pfizer INC. | $37.12 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $32.94 | 2022 | |
| Abbott Laboratories | $31.44 | 2025 | Jot Dx |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.44 | 2025 | Caplyta |
| Organon LLC | $21.05 | 2024 | |
| Dexcom, INC. | $18.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.95 | 2021 | |
| Medtronic Vascular, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Root listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.